The California End of Life Option Act (EOLOA),1 which took effect on June 9, 2016, allows qualified adults diagnosed with a terminal disease to request aid-in-dying drugs from their physician. The California Department of Public Health recently published data on 191 individuals who received aid-in-dying prescriptions during the act’s first 6 months.2 In response to recommendations for more comprehensive documentation of EOLOA implementation to improve end-of-life care,3 this study describes the experience of a large integrated health system and provides in-depth descriptions of individuals who initiated the EOLOA process.
Nguyen HQ, Gelman EJ, Bush TA, Lee JS, Kanter MH. Characterizing Kaiser Permanente Southern California’s Experience With the California End of Life Option Act in the First Year of Implementation. JAMA Intern Med. 2018;178(3):417–421. doi:10.1001/jamainternmed.2017.7728
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: